How do proteins recognize the right partners among thousands of possibilities?
We combine structural biology, computational design, and machine learning to answer this question — and to design peptide inhibitors targeting cancer proteins, autophagy regulators, and bacterial defense systems. Our work bridges fundamental molecular recognition to biomedical applications.